Literature DB >> 11001571

Sphingomyelin-degrading pathways in human cells role in cell signalling.

T Levade1, N Andrieu-Abadie, B Ségui, N Augé, M Chatelut, J P Jaffrézou, R Salvayre.   

Abstract

The ubiquitous sphingophospholipid sphingomyelin (SM) can be hydrolysed in human cells to ceramide by different sphingomyelinases (SMases). These enzymes exert a dual role, enabling not only the turnover of membrane SM and the degradation of exogenous (lipoprotein) SM, but also the signal-induced generation of the lipid second messenger ceramide. This review focuses on the function(s) of the different SMases in living cells. While both lysosomal and non-lysosomal pathways that ensure SM hydrolysis in intact cells can be distinguished, the precise contribution of each of these SM-cleaving enzymes to the production of ceramide as a signalling molecule remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11001571     DOI: 10.1016/s0009-3084(99)00085-7

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  6 in total

1.  A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling.

Authors:  R J Veldman; N Maestre; O M Aduib; J A Medin; R Salvayre; T Levade
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

2.  Phosphatidylinositol transfer protein beta displays minimal sphingomyelin transfer activity and is not required for biosynthesis and trafficking of sphingomyelin.

Authors:  Bruno Ségui; Victoria Allen-Baume; Shamshad Cockcroft
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

3.  Endocytic trafficking of sphingomyelin depends on its acyl chain length.

Authors:  Mirkka Koivusalo; Maurice Jansen; Pentti Somerharju; Elina Ikonen
Journal:  Mol Biol Cell       Date:  2007-10-17       Impact factor: 4.138

4.  Plasma sphingomyelin and longitudinal change in percent emphysema on CT. The MESA lung study.

Authors:  Firas S Ahmed; Xian-cheng Jiang; Joseph E Schwartz; Eric A Hoffman; Joseph Yeboah; Steven Shea; Kristin Marie Burkart; R Graham Barr
Journal:  Biomarkers       Date:  2014-03-21       Impact factor: 2.658

5.  Changes of plasmalogen phospholipid levels during differentiation of induced pluripotent stem cells 409B2 to endothelial phenotype cells.

Authors:  Yusuke Nakamura; Yasuo Shimizu; Yasuhiro Horibata; Rinna Tei; Ryosuke Koike; Meitetsu Masawa; Taiji Watanabe; Taichi Shiobara; Ryo Arai; Kazuyuki Chibana; Akihiro Takemasa; Hiroyuki Sugimoto; Yoshiki Ishii
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

6.  Quantitative analysis of sphingomyelin by high-performance liquid chromatography after enzymatic hydrolysis.

Authors:  Seunghyun Lee; Youn-Sun Lee; Kyeong-Mi Choi; Kwang-Sik Yoo; Dong-Mi Sin; Wonkyun Kim; Yong-Moon Lee; Jin-Tae Hong; Yeo-Pyo Yun; Hwan-Soo Yoo
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-05       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.